Tag "ibb"

Biotech ETF (XBI) On The Brink Of A Breakout

The volatility in the biotech space over the last two years has been quite a sight to behold. I’m not strictly speaking of volatility in terms of downside either. There has been money to be made on both sides of the market for those that have been nimble in their…

Biotech Sector (IBB): A Closer Look At The 2017 Rally

The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing. On Wednesday, it finished off by -2.99%. While that decline was sharp, and may have hit a few traders, there was a silver lining for opportunistic traders (and I shared this yesterday on my…

Options Traders Look For Q2 Upside In Biotech Stocks

Biotech was a sector that was a notable laggard in Q1 with the Nasdaq Biotech Sector ETF (IBB) down nearly 24% and S&P Biotech Sector ETF (XBI) down nearly 28%. The relative weakness started to show in Q3 and Q4 of 2015 after the group became overheated after an 80%…

Biotech Sector: A Breakout Would Be Huge For The Market

When it comes to leadership in the stock market, the Biotech sector has filled that role quite well during this bull market. And it has been a great signal for market pullbacks and thrusts higher. Here’s a look at how the Biotech sector ETF (IBB) did compared to the S&P 500…

Biotech Sector (IBB) Signals Downtrend Not Over

The S&P 500 has bounced nearly 8 percent over the last 8 trading days giving many investors hope for better days ahead. Perhaps a return to the BTFD days of 2013-2014? Before going all in, it’s important to look at the broader market and not just the major stock market…

Market Outlook: Are Bond Bulls Ready To Run Higher?

In last week’s market outlook (“Stalemate“) I speculated about the potential danger of the market getting what it wanted from the Fed, namely no increase in interest rates. My view was that this could send a signal that the global economies were weaker than expected, hardly an outcome favoring the…

Market Update: It’s Getting Lonely At The Top

Stock market bulls continued to struggle mightily to retain any semblance of control over what seems like the growing tide of weakness. Despite losing Apple (AAPL) to the bears, the S&P 500 actually had a decent rally attempt through the 2110 level on Wednesday. The bears, though, did not have much…

Can The Biotech Sector (IBB) Regain Its Swagger?

The once left for dead Biotech Sector has re-awakened. The group is experiencing some of the same ‘this is it, it’s over’ sentiment that the U.S stock market has faced for the last 3 years. Biotech stocks have been lagging the markets and its popular sector ETF, Biotech iShares (IBB), is at a crucial…